News

Alnylam Pharmaceuticals has received a milestone payment from its partner Roche, related to initiation of pre-IND (investigational new drug application) studies for an RNAi therapeutics product candidate. Financial

Wockhardt has received tentative approval from the FDA for marketing the 5mg and 10mg tablets of Memantine HCI, which is used for treatment of moderate to severe Alzheimer’s

GenVault has launched GenTegra RNA. GenTegraRNA is an inert chemical matrix that inactivates trace RNase in the liquid phase, providing an added level of RNA stability during sample

Enzon Pharmaceuticals (Enzon) has treated its first patient in the phase 2 studies of PEG-SN38 for metastatic breast cancer. PEG-SN38 or EZN-2208 is Enzon’s PEGylated form of SN38,

The European Commission has granted marketing approval for BioMarin’s 3,4-diaminopyridine (amifampridine phosphate), for the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). Reportedly, Amifampridine phosphate, developed by the

NeoPharm has reported the results of a Phase II clinical trial of Liposome-Entrapped Paclitaxel (LEP) an active component of Taxol. The multicenter, open-label trial of LEP was conducted

Pearl Therapeutics has announced positive results from a phase 2a dose-ranging study of PT001, the company’s glycopyrrolate hydrofluoroalkane metered dose inhaler (HFA-MDI) formulation. The data showed that PT001

American Associated Pharmacies (AAP) has selected Cardinal Health to be the exclusive pharmaceutical distributor for its nearly 2,000 independent pharmacy members, nationwide. The new, multi-year agreement, effective Jan

United Drug is going to implement Pilgrim Software’s SmartSolve solution to standardise its quality and compliance operations. The former was seeking an integrated Quality Management System (QMS) that